For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Chimerix, Inc.

USPTO Granted Patents = 28

% Expired Patents = 17.9

CIPO Patents = 3

EPO Patents = 10

Trademarks = 2

Forward Citations = 479

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Roy Wendell Ware (16 out of 18 patents)

Ernest Randall Lanier, Jr (11 out of 11 patents)

Aaron Leigh Downey (10 out of 11 patents)

4. Merrick R Almond (9 out of 19 patents)

5. John Henry Bougher, Iii (5 out of 5 patents)

6. Andrew Louis McIver (5 out of 9 patents)

7. Bradley David Robertson (5 out of 5 patents)

8. Phiroze Behram Sethna (5 out of 5 patents)

9. Ramamurty V S Changalvala (5 out of 5 patents)

10. Dean Wallace Selleseth (5 out of 5 patents)

11. George R Painter (5 out of 26 patents)

12. John Charles Drach (5 out of 41 patents)

13. Leroy B Townsend (5 out of 44 patents)

14. Karl Y Hostetler (4 out of 73 patents)

15. Bernhard Lampert (4 out of 4 patents)

28 patents: Sort by Forward Citations

1. 11981700 - Pyrrolopyrimidine nucleosides and analogs thereof (2024-05-14),

2. 11111264 - Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof (2021-09-07),

3. 11066373 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2021-07-20),

4. 10941175 - Pyrrolopyrimidine nucleosides and analogs thereof (2021-03-09),

5. 10487061 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2019-11-26),

6. 10407457 - Pyrrolopyrimidine nucleosides and analogs thereof (2019-09-10),

7. 10112909 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2018-10-30),

8. 9956239 - Methods of treating retroviral infections and related dosage regimes (2018-05-01),

9. 9862687 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2018-01-09),

10. 9765100 - Nucleoside phosphonate salts (2017-09-19),

11. 9708359 - Pyrrolopyrimidine nucleosides and analogs thereof (2017-07-18),

12. 9701706 - Pyrrolopyrimidine nucleosides and analogs thereof (2017-07-11),

13. 9694024 - Methods of treating retroviral infections and related dosage regimes (2017-07-04),

14. 9371344 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2016-06-21),

15. 9303051 - Phosphonate ester derivatives and methods of synthesis thereof (2016-04-05),

Chimerix, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious and life-threatening diseases. They leverage their proprietary lipid conjugate technology platform to develop novel antiviral and oncology therapies. With a deep pipeline of innovative drug candidates, Chimerix aims to provide patients with improved treatment options and better outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

28 Patents

#36 in Durham, NC

#269 in North Carolina

#11,986 in US

#23,215 in the World

Durham, NC, United States of America

Chimerix, Inc.

Forward Citations = 479

26 inventors:

Roy Wendell Ware (16 out of 18 patents)

Ernest Randall Lanier, Jr (11 out of 11 patents)

Aaron Leigh Downey (10 out of 11 patents)

4. Merrick R Almond (9 out of 19 patents)

5. John Henry Bougher, Iii (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…